← Eichor
Condition: Recurrent Craniopharyngioma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Recurrent Craniopharyngioma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
Phase 2 · 20 location(s) · Sabine Mueller, MD, PhD · NCT05465174Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma
Phase 1/Phase 2 · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06970145MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Phase 2 · 10 location(s) · Nationwide Children's Hospital · NCT05286788ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Phase 2 · 14 location(s) · Nationwide Children's Hospital · NCT05233397
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.